Interestingly, a high expression of LOX-1 was reported on polymorphonuclear myeloid-derived suppressor cells from peripheral blood and tumor of cancer patients (up to 5–50%), whereas its expression is almost undetectable on blood neutrophils from healthy donors (73). This evidence concerns the gene OLR1 and neoplasm.